Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

U.S./EU drug agency collaboration

This article was originally published in The Tan Sheet

Executive Summary

FDA and the European Medicines Agency extend their confidentiality arrangement related to medicinal products indefinitely "without the need for further renewal," EMA announces Sept. 15. The collaboration allows the agencies to exchange confidential information as part of their regulatory and scientific processes, including scientific advice and data on good manufacturing practice and good clinical practice inspection reports, marketing authorization procedures and post-marketing surveillance. The extension follows their initial deal signed in 2003
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS104526

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel